| Page 857 | InsideHealthPolicy.com

Future Universal Vaccine A Key Part Of White House COVID-19 Strategy

The Biden administration wants to accelerate research and development of a universal SARS-CoV-2 vaccine that protects against COVID-19 and all its variants, and officials plan to ask Congress to provide additional funding to support development efforts, the White House says in its national COVID-19 response strategy released Wednesday (March 2). It’s unclear how much money the administration would like from Congress. White House COVID-19 Response Coordinator Jeff Zients said the administration will work with lawmakers in the coming weeks to...

Article Type:

Daily News

Tags:

Site Name:

InsideHealthPolicy.com

FDA Issue:

FDA Week - 03/04/2022

FDA Volume:

Vol. 28, No. 9

Author:

Beth Wang

Topics:

ISSUE: FDA WEEK

Biden Health Agenda

Coronavirus

Rx Drugs

WH Plan To Tackle COVID Hinges On Quick Reviews, Small Trials, Funding

The Biden administration is calling for Congress to provide funding to support streamlined FDA review and development of future COVID-19 vaccines and therapies, including variant-specific products that can be quickly developed, authorized and deployed should they be needed in the future. The funding request is part of the administration’s wide-ranging strategy to tackle COVID-19 going forward, which was laid out in a 96-page report released Wednesday (March 2) . White House COVID-19 Response Coordinator Jeff Zients said the administration will...